Using this induced CAF model, we screened out the TRPC3 gene expressed in CAFs as a biomarker, and confirmed that it influences the invasion and migration ability of cancer cells, promoting the progression of colon cancer by activating the NF-κB signaling pathway. This evidence concerns the gene TRPC3 and colonic neoplasm.